Aurovela 1.5/30 Interactions
There are 459 drugs known to interact with Aurovela 1.5/30 (ethinyl estradiol/norethindrone), along with 24 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 52 are major, 360 are moderate, and 47 are minor.
- View all 459 medications that may interact with Aurovela 1.5/30
- View Aurovela 1.5/30 alcohol/food interactions (8)
- View Aurovela 1.5/30 disease interactions (24)
Most frequently checked interactions
View interaction reports for Aurovela 1.5 / 30 (ethinyl estradiol / norethindrone) and the medicines listed below.
- acetaminophen / aspirin / codeine
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- albuterol
- alprazolam
- amitriptyline
- baclofen
- Beano (alpha-d-galactosidase)
- cannabis
- Caplyta (lumateperone)
- Celebrex (celecoxib)
- cetirizine
- Claritin (loratadine)
- Concerta (methylphenidate)
- Contrave (bupropion / naltrexone)
- CoQ10 (ubiquinone)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Deplin (l-methylfolate)
- desvenlafaxine
- doxepin
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- fluoxetine
- gabapentin
- Singulair (montelukast)
- tizanidine
- trazodone
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Aurovela 1.5/30 alcohol/food interactions
There are 8 alcohol/food interactions with Aurovela 1.5 / 30 (ethinyl estradiol / norethindrone).
Aurovela 1.5/30 disease interactions
There are 24 disease interactions with Aurovela 1.5 / 30 (ethinyl estradiol / norethindrone) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Aurovela 1.5 / 30 (ethinyl estradiol / norethindrone)
- Aurovela 1.5/30 consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.